Cytochrome P450 Hydroxylation of 7-Deoxysteroids at Position 7
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inefficient in selectively introducing a hydroxyl group at position 7 of complex molecules like bile acids, leading to limited production capacity and high costs due to the difficulty in hydroxylating deoxycholic acid into 3,7,12-trihydroxylated bile acids.
Innovation Solution
Employing cytochrome P450 hydroxylase or functional variants with a specific amino acid sequence, coupled with a redox partner system, to selectively hydroxylate 7-deoxysteroids at position 7, using recombinantly expressed enzymes in the presence of redox cofactors like NAD(P)H.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional chemical hydroxylation methods are used to introduce a hydroxyl group at position 7 of deoxycholic acid, then the reaction can proceed with available reagents, but the selectivity is poor due to the presence of several chemically equivalent C-H bonds, leading to low manufacturing precision
Solution Approach 1:
The patent employs cytochrome P450 monooxygenase as a biological intermediary catalyst to achieve selective hydroxylation at position 7 of deoxycholic acid. This enzyme specifically recognizes and catalyzes the hydroxylation reaction at the desired position, avoiding the non-selective chemical hydroxylation of other C-H bonds. The use of this biological mediator resolves the contradiction by providing high selectivity while maintaining practical manufacturability through enzymatic catalysis.
2Productivity
If bile is used as the raw material source for producing 3,7,12-trihydroxylated bile acids, then the production is linked to meat production with limited response to increased demands, but using alternative sources or methods would require developing new production pathways
Solution Approach 1:
The patent changes the production pathway by employing enzymatic hydroxylation of deoxycholic acid using cytochrome P450 monooxygenase. This parameter change from chemical to biological catalysis enables independent production not tied to meat byproducts, allowing flexible scaling to meet increased demands. The enzymatic method can process deoxycholic acid from various sources and produce the desired trihydroxylated bile acids with high efficiency and selectivity.
3Quantity of substance
If deoxycholic acid is converted to 3,7,12-trihydroxylated bile acids through selective hydroxylation at position 7, then the commercial value is significantly increased, but the reaction equilibrium limits the yield and production efficiency
Solution Approach 1:
The patent employs a coupled enzyme system where cytochrome P450 monooxygenase catalyzes the hydroxylation reaction and is coupled with a redox partner system that regenerates the reduced form of the enzyme. This feedback mechanism ensures continuous catalytic activity by rapidly regenerating the active form of the enzyme, preventing accumulation of oxidized form and maintaining high reaction rates. This resolves the contradiction by sustaining high productivity while achieving high yield through complete conversion.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Significantly increases the yield of 3,7,12-trihydroxylated bile acids by shifting the reaction equilibrium, enhancing the production efficiency and converting deoxycholic acid into valuable 3,7,12-trihydroxylated bile acids.
Implementation Method 1
During hydroxylations, an oxygen atom is formally introduced into a (non-activated) C—H bond in an oxidation reaction
Implementation Method 2
converting a 7-deoxysteroid having the general formula (II) with a cytochrome P450 hydroxylase or a functional variant thereof
Implementation Method 3
in the presence of at least one redox partner system and a system for regenerating the redox partner system
Data Source
AI summary
The present invention relates to a method of preparing a steroid comprising the step of converting a 7-deoxysteroid with a cytochrome P450 enzyme or a functional variant thereof in the presence of at least one redox partner system and a system for regenerating the redox partner system.